---
title: "Hepatocellular Carcinoma in Dogs: Understanding This Common Liver Cancer"
description: Hepatocellular carcinoma is a common primary liver cancer in dogs. Learn about the different forms, treatment options, and prognosis for this disease.
image: https://blog.fidocure.com/hubfs/Blog_HC.png
---

[![FidoCure](https://blog.fidocure.com/hs-fs/hubfs/fidocure_logo.png?width=296&height=68&name=fidocure_logo.png "FidoCure")](https://www.fidocure.com/)

- [Veterinarians](https://fidocure.com/for-veterinarians/) 
    - [Portal Login](https://dvm.fidocure.com/)
    - [Veterinary Blog](https://blog.fidocure.com/fidocure-blog/tag/vet)
    - [Case Studies](https://blog.fidocure.com/fidocure-blog/tag/case-studies)
    - [Webinars](https://blog.fidocure.com/fidocure-blog/tag/webinars)
- [Pet Parents](https://fidocure.com/pet-parents/)
- [About Us](https://fidocure.com/about-us/)
- [How it works](https://fidocure.com/how-it-works/)
- [Find a Clinic](https://fidocure.com/find-a-clinic/)
- [Contact Us](https://fidocure.com/contact-us/)

# Hepatocellular Carcinoma in Dogs: Understanding This Common Liver Cancer

![FidoCure](https://blog.fidocure.com/hs-fs/hubfs/Screen%20Shot%202023-05-08%20at%2011.54.38%20AM.png?width=45&name=Screen%20Shot%202023-05-08%20at%2011.54.38%20AM.png) 

[FidoCure](https://blog.fidocure.com/fidocure-blog/author/fidocure)

[Share this blog post on Twitter](https://twitter.com/intent/tweet?text=I+found+this+interesting+blog+post&url=https://blog.fidocure.com/fidocure-blog/hepatocellular-carcinoma-in-dogs-understanding-this-common-liver-cancer) [Share this blog post on Facebook](http://www.facebook.com/share.php?u=https://blog.fidocure.com/fidocure-blog/hepatocellular-carcinoma-in-dogs-understanding-this-common-liver-cancer) [Share this blog post on LinkedIn](http://www.linkedin.com/shareArticle?mini=true&url=https://blog.fidocure.com/fidocure-blog/hepatocellular-carcinoma-in-dogs-understanding-this-common-liver-cancer)

Hepatocellular carcinoma (HCC) is the most common primary liver cancer in dogs. It can present as a single mass, multiple nodules, or diffuse spread throughout the liver, which increases the risk of metastasis. The main treatment options are surgical removal, metronomic chemotherapy, and/or Palladia. The prognosis is generally good for the single, massive form after surgery, but consulting a veterinary oncologist is recommended for all cases.

The most common form of HCC is a single, large mass ([massive form).](https://vcahospitals.com/know-your-pet/liver-tumors-epithelial) However, HCC can also present as multiple small nodules (nodular form) or with cancer cells spread throughout the liver (diffuse form). The nodular and diffuse forms are more likely to spread to other organs, such as lymph nodes, the abdominal lining, and the lungs. While no specific breed or sex is more prone to HCC, some studies suggest that miniature schnauzers may be diagnosed with HCC more frequently than other breeds.

**Treatment Options**

The main treatment for HCC is surgery to remove the tumor and/or the affected liver lobe. In some cases, if the entire mass can be surgically removed, no further treatment may be needed. However, if surgery cannot remove all the cancer cells or if the cancer returns, chemotherapy may be used to delay its progression.

Chemotherapy is generally well-tolerated in dogs, with minimal to no side effects. Potential side effects can include fatigue, loss of appetite, vomiting, and diarrhea. Several chemotherapy options exist for HCC, including traditional injectable chemotherapy drugs and metronomic chemotherapy. In dogs, as in humans, anti-angiogenic therapies such as Palladia (toceranib) or sorafenib have been used to target tumor blood vessel growth, helping to slow tumor progression. These targeted oral drugs can be used for HCC and are taken daily at home, but may require regular check-ups to monitor tolerance and treatment response.

**Prognosis**

For the massive HCC form, the prognosis is generally good after surgically removing the affected lobe, with low rates of cancer returning locally or metastasizing. In contrast, the nodular and diffuse forms of HCC have a poorer prognosis because the involvement of multiple liver lobes often makes surgery impossible. Additionally, these forms of the disease are highly likely to metastasize.

For the most accurate prognosis and treatment recommendations for your dog with hepatocellular carcinoma, consult your veterinarian or a veterinary oncologist. They can provide personalized guidance based on your dog's specific case, considering factors such as cancer stage, grade, tumor location, and concurrent health issues.

 

## Related Articles

[![](https://blog.fidocure.com/hubfs/Blog_PancreaticCancer.png)](https://blog.fidocure.com/fidocure-blog/pancreatic-cancer-in-dogs)

### [Pancreatic Cancer in Dogs](https://blog.fidocure.com/fidocure-blog/pancreatic-cancer-in-dogs)

Pancreatic cancer, though rare, is a serious condition in dogs, with two of the most common forms being insulinoma and pancreatic adenocarcinoma. These tumors can be...

![FidoCure](https://blog.fidocure.com/hs-fs/hubfs/Screen%20Shot%202023-05-08%20at%2011.54.38%20AM.png?width=45&name=Screen%20Shot%202023-05-08%20at%2011.54.38%20AM.png) 

[FidoCure](https://blog.fidocure.com/fidocure-blog/author/fidocure) 

[Read More](https://blog.fidocure.com/fidocure-blog/pancreatic-cancer-in-dogs)

[![dna helix](https://blog.fidocure.com/hubfs/iStock-1328132549-1.jpg)](https://blog.fidocure.com/fidocure-blog/how-genomic-testing-is-revolutionizing-canine-cancer-treatment)

[Vet](https://blog.fidocure.com/fidocure-blog/tag/vet)

### [How Genomic Testing Is Revolutionizing Canine Cancer Treatment](https://blog.fidocure.com/fidocure-blog/how-genomic-testing-is-revolutionizing-canine-cancer-treatment)

#### Cancer is one of the biggest unmet needs in the veterinary world, despite the fact that canine cancer research shares a great deal of overlap with human oncology....

![FidoCure](https://blog.fidocure.com/hs-fs/hubfs/Screen%20Shot%202023-05-08%20at%2011.54.38%20AM.png?width=45&name=Screen%20Shot%202023-05-08%20at%2011.54.38%20AM.png) 

[FidoCure](https://blog.fidocure.com/fidocure-blog/author/fidocure) 

[Read More](https://blog.fidocure.com/fidocure-blog/how-genomic-testing-is-revolutionizing-canine-cancer-treatment)

![fc_portal_logo_bw](https://blog.fidocure.com/hubfs/fc_portal_logo_bw.svg)

- [How it Works](https://fidocure.com/how-it-works/)
- [FAQ](https://fidocure.com/faq/)
- [Contact Us](https://fidocurestg.wpengine.com/contact-us/)
- [For Vets](https://fidocure.com/for-veterinarians/)
- [About Us](https://fidocure.com/about-us/)
- [Terms of Service](https://fidocure.com/terms-of-service/)
- [Blog](https://blog.fidocure.com/fidocure-blog)
- [Careers](https://fidocure.com/careers/)
- [Privacy Policy](https://fidocure.com/privacy-policy/)

- <https://www.instagram.com/fidocure/>
- <https://twitter.com/fidocure>
- <https://www.facebook.com/FidoCure/>
- <https://www.pinterest.com/fidocure/>

**FidoCure® is an advanced cancer-care service for dogs, developed by One Health Company**. DISCLAIMER: All patients are enrolled in FidoCure® by a veterinarian with a valid veterinarian-client-patient relationship (VCPR). We use best efforts to inform the veterinarian on available targeted therapy options for patients. FidoCure® does not prescribe therapy. The targeted therapies that veterinarians may prescribe and order from compounding pharmacies, after receiving genetic test results from FidoCure®, may constitute extra-label uses of those drugs. FidoCure® makes no claims that every patient will have genetic test results that lead to targeted therapy options. FidoCure® makes no claims or guarantees about the effectiveness of the diagnostic and targeted therapy selected by the veterinarian for an individual patient. Like most cancer care approaches, the services provided by FidoCure® are not a guarantee of a cure. FidoCure® is not a pharmacy and does not supply drugs directly. By ordering any medication via one of our pharmacy partners, you agree that the pharmacy, not FidoCure®, is solely responsible and liable for any and all issues relating to the preparation, dispensation and fulfillment of the medication. The lifetime offer is subject to the commercially reasonable availability of any medication(s) and/or active pharmaceutical ingredient(s) necessary for the selected therapy. 

© Copyright 2018-2026 One Health Company, All rights reserved

```json
{
  "@context" : "https://schema.org",
  "@type" : "BlogPosting",
  "author" : {
    "@type" : "Person",
    "name" : "FidoCure",
    "url" : "https://blog.fidocure.com/fidocure-blog/author/fidocure"
  },
  "dateModified" : "2024-09-12T13:00:02.576Z",
  "datePublished" : "2024-09-12T13:00:00.000Z",
  "headline" : "Hepatocellular Carcinoma in Dogs: Understanding This Common Liver Cancer",
  "image" : [ "https://blog.fidocure.com/hubfs/Blog_HC.png" ],
  "mainEntityOfPage" : {
    "@id" : "https://blog.fidocure.com/fidocure-blog/hepatocellular-carcinoma-in-dogs-understanding-this-common-liver-cancer",
    "@type" : "WebPage"
  },
  "publisher" : {
    "@type" : "Organization",
    "logo" : {
      "@type" : "ImageObject",
      "url" : "https://blog.fidocure.com/hubfs/fidocure_logo.png"
    },
    "name" : "FidoCure"
  }
}
```